Novel Rehabilitation Strategies to Improve Arm Function in Patients With Scleroderma
Primary Purpose
Scleroderma, Ssc
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Occupational therapy treatment
Sponsored by
About this trial
This is an interventional treatment trial for Scleroderma
Eligibility Criteria
Inclusion Criteria:
- diagnosis of scleroderma (localized or generalized morphea)
- Have a contracture of the hand and other joint in at least one arm, such as wrist, elbow, or shoulder, with the ability to demonstrate active range of motion in that arm
- Willing to travel to participate in therapy and outcome assessments.
- English speaking
Exclusion Criteria:
- active hand ulcers
Sites / Locations
- University of Michigan
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Occupational therapy treatment
Arm Description
Participants will undergo the following as appropriate: Thermal Modalities Hot packs, focused on areas with limitations Paraffin, focused on digital limitations Application of the Physiotouch (a low-intensity negative pressure device) Passive Range of Motion Active Range of Motion Functional Activities
Outcomes
Primary Outcome Measures
quickDASH
self-report questionnaire of physical function and symptoms
Secondary Outcome Measures
Upper extremity range of motion
Active and Passive Range of Motion measured by goniometer
Coordination
9 hole peg test
Grip Strength
dynanometer
Physical Function
PROMIS physical function 8-item short form
Full Information
NCT ID
NCT02837549
First Posted
July 5, 2016
Last Updated
October 24, 2017
Sponsor
University of Michigan
Collaborators
University of Alabama at Birmingham
1. Study Identification
Unique Protocol Identification Number
NCT02837549
Brief Title
Novel Rehabilitation Strategies to Improve Arm Function in Patients With Scleroderma
Official Title
Novel Rehabilitation Strategies to Improve Arm Function in Patients With Scleroderma
Study Type
Interventional
2. Study Status
Record Verification Date
October 2017
Overall Recruitment Status
Completed
Study Start Date
July 2016 (undefined)
Primary Completion Date
September 2017 (Actual)
Study Completion Date
September 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Michigan
Collaborators
University of Alabama at Birmingham
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to determine the feasibility and preliminary effects of a novel treatment approach to improve arm function in patients with scleroderma who have upper extremity contractures. It is a Phase 1, one arm trial in which participants will be assessed at baseline, 4 weeks, and 8 weeks. The rehabilitation intervention will involve 8 individual sessions with an occupational therapist. Feasibility of the procedures is a major focus of this project.
Detailed Description
Our specific aims are to:
Determine the feasibility of a novel rehabilitation strategy provided at the University of Michigan Scleroderma Clinic to scleroderma patients who have upper extremity contractures.
Investigators will assess 3 main aspects of the process that are key to the success of a larger study including the proportion of eligible people who enroll in the study, rate of adherence to the treatment protocol, and the time it takes to conduct sessions including treatment and outcome assessment completion. Based on a framework of recommendations for well-designed pilot studies [1], investigators have set the following criteria for success to examine these aspects:
At least 50% of participants who are eligible for the study will enroll.
At least 80% of participants will attend all treatment sessions.
The 3 sessions involving both treatment and outcome assessments will not last on average more than 2 hours.
Develop a standardized treatment manual to train therapists to provide this treatment to their patients.
A standardized treatment manual for therapists is a critical component needed to ensure consistency in a larger multi-site trial. This manual will be drafted for use in this study and refined as needed.
Establish preliminary effects of this 8-week rehabilitation program on improving arm function.
Investigators hypothesize that participants with scleroderma will have significant improvements in the QuickDASH disability measure at post test. Although the investigators think large effects will be shown, this study will allow us to determine estimates of the effects and the variability for power calculations in a multi-site trial.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Scleroderma, Ssc
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
21 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Occupational therapy treatment
Arm Type
Experimental
Arm Description
Participants will undergo the following as appropriate:
Thermal Modalities Hot packs, focused on areas with limitations Paraffin, focused on digital limitations
Application of the Physiotouch (a low-intensity negative pressure device)
Passive Range of Motion
Active Range of Motion
Functional Activities
Intervention Type
Other
Intervention Name(s)
Occupational therapy treatment
Other Intervention Name(s)
Upper Extremity Rehabilitation
Intervention Description
This intervention includes various thermal modalities, manual therapy, Physiotouch (Healthy Life Devices Ltd) and education
Primary Outcome Measure Information:
Title
quickDASH
Description
self-report questionnaire of physical function and symptoms
Time Frame
change over 8 weeks
Secondary Outcome Measure Information:
Title
Upper extremity range of motion
Description
Active and Passive Range of Motion measured by goniometer
Time Frame
change over 8 weeks
Title
Coordination
Description
9 hole peg test
Time Frame
change over 8 weeks
Title
Grip Strength
Description
dynanometer
Time Frame
change over 8 weeks
Title
Physical Function
Description
PROMIS physical function 8-item short form
Time Frame
change over 8 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
diagnosis of scleroderma (localized or generalized morphea)
Have a contracture of the hand and other joint in at least one arm, such as wrist, elbow, or shoulder, with the ability to demonstrate active range of motion in that arm
Willing to travel to participate in therapy and outcome assessments.
English speaking
Exclusion Criteria:
active hand ulcers
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Susan Murphy, ScD
Organizational Affiliation
University of Michigan - Department of Physical Medicine and Rehabilitation
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Michigan
City
Ann Arbor
State/Province
Michigan
ZIP/Postal Code
48109
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
Undecided
IPD Sharing Plan Description
upon written request
Citations:
PubMed Identifier
29381834
Citation
Murphy SL, Barber MW, Homer K, Dodge C, Cutter GR, Khanna D. Occupational Therapy Treatment to Improve Upper Extremity Function in Individuals with Early Systemic Sclerosis: A Pilot Study. Arthritis Care Res (Hoboken). 2018 Nov;70(11):1653-1660. doi: 10.1002/acr.23522.
Results Reference
derived
Learn more about this trial
Novel Rehabilitation Strategies to Improve Arm Function in Patients With Scleroderma
We'll reach out to this number within 24 hrs